Abstract
Paired samples of saliva and serum from 286 highrisk subjects were tested for HIV using two commercial enzyme immunoassays following the same WHO testing strategy supplemented with a Western blot technique. Agreement between HIV testing in both sample types was 98.9 % (95 % confidence interval: 97.7–100). The sensitivity of an EIA (Wellcozyme GACELISA) alone for saliva was 100% (133/133) and the specificity 98.7% (151/153). These results support previous data showing that in some situations saliva might be an effective alternative to serum for HIV testing.
Similar content being viewed by others
References
Johnson AM, Parry JV, Best SJ, Smith AM, de Silva M, Mortimer PP: HIV surveillance by testing saliva. AIDS 1988, 2: 369–371.
Major CJ, Read SE, Coates RA, Francis A, McLaughlin BJ, Millson M, Shepherd F, Fanning M, Calzavara L, MacFadden D, Johnson JK, O'Shaughnessy MV: Comparison of saliva and blood for human immunodeficiency virus prevalence testing. Journal of Infectious Diseases 1991, 163: 699–702.
Frerichs R, Silarug N, Eskes N, Pagcharoenpol P, Rodklai A, Thangsupachai S, Wongba C: Saliva-based HIV-testing in Thailand. AIDS 1994, 8: 885–894.
WHO/Global Programme on AIDS: HIV antibody detection in oral fluids. Weekly Epidemiological Record 1993, 19: 133–134.
Tamashiro H, Constantine NT: Serological diagnosis of HIV infection using oral fluid samples. Bulletin of the World Health Organization 1994, 72: 135–143.
Tamashiro H, Maskill W, Emmanuel J, Fauquex A, Sato P, Heymann D: Reducing the cost of HIV antibody testing. Lancet 1993, 342: 87–90.
Soto-Ramirez LE, Hernández-Gómez L, Sifuentes-Osorino J, Barriga-Angulo G, Durate de Lima D, López-Portillo M, Ruiz-Palacios GM: Detection of specific antibodies in gingival crevicular transudate by enzymelinked immunosorbent assay for diagnosis of human immunodeficiency virus type 1 infection. Journal of Clinical Microbiology 1992, 30: 2780–2783.
Sato PA, Maskill WJ, Tamashiro H, Heymann DL: Strategies for laboratory HIV testing: an examination of alternative approaches not requiring Western blot. Bulletin of the World Health Organization 1994, 72: 129–134.
Connell JA, Parry JV, Mortimer PP, Duncan J: Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine. Journal of Medical Virology 1993, 41: 159–164.
Frerichs RR, Eskes N, Htoon MT: Validity of three assays for HIV-1 antibodies in saliva. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 1994, 7: 522–524.
Unlinked anonymous monitoring of HIV prevalence in England and Wales: 1990–92. Communicable Disease Report 1993, 3: R1–R11.
Behets FM, Edidi B, Quinn TC, Atikala L, Bishagara K, Nzila N, Laga M, Piot P, Ryder RW, Brown CC: Detection of salivary HIV-1-specific IgG antibodies in highrisk populations in Zaire. Journal of Acquired Immunodeficiency Syndrome 1991, 4: 183–187.
Goldberg DJ, Tappin DM, Cameron S, Frischer M, Green ST, Follet EAC: Saliva and HIV testing. Lancet 1993, 341: 382.
Frerichs R, Htoon MT, Eskes N, Lwin S: Comparison of saliva and serum for HIV surveillance in developing countries. Lancet 1992, 340: 1496–1499.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mayans, M.V., Casabona, J., Rabella, N. et al. Testing of saliva and serum for HIV in high-risk populations. Eur. J. Clin. Microbiol. Infect. Dis. 14, 710–713 (1995). https://doi.org/10.1007/BF01690881
Issue Date:
DOI: https://doi.org/10.1007/BF01690881